[Translation] Zephyrus II: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pamrevlumab in Idiopathic Pulmonary Fibrosis (IPF)
本研究的总体目的是与安慰剂对比,在特发性肺纤维化患者中评价Pamrevlumab的有效性和安全性。
[Translation] The overall objective of this study was to evaluate the efficacy and safety of pamrevlumab compared with placebo in patients with idiopathic pulmonary fibrosis.